Titan Pharmaceuticals
TTNP
#10719
Rank
โ‚น0.57 B
Marketcap
โ‚น434.86
Share price
-3.76%
Change (1 day)
26.51%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น414.11. In 2023 the company made an earnings per share (EPS) of -โ‚น698.99 an increase over its 2022 EPS that were of -โ‚น1,433.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น698.99-51.22%
2022-โ‚น1,433-15.61%
2021-โ‚น1,698-81.37%
2020-โ‚น9,112-77.52%
2019-โ‚น40,543-56.32%
2018-โ‚น92,822-59.51%
2017-โ‚น2,29,270-371.81%
2016โ‚น84,349-144.35%
2015-โ‚น1,90,171300%
2014-โ‚น47,543-121.54%
2013โ‚น2,20,734-151.38%
2012-โ‚น4,29,583-11.54%
2011-โ‚น4,85,615188.89%
2010-โ‚น1,68,098-10%
2009-โ‚น1,86,775
2007-โ‚น7,65,778-2.38%
2006-โ‚น7,84,455-39.13%
2005-โ‚น12,88,748-16.87%
2004-โ‚น15,50,233-22.43%
2003-โ‚น19,98,4934.9%
2002-โ‚น19,05,10661.9%
2001-โ‚น11,76,683-13.7%
2000-โ‚น13,63,45865.01%
1999-โ‚น8,26,302-35.87%
1998-โ‚น12,88,528-1824.71%
1997โ‚น74,710-102.4%
1996-โ‚น31,19,144

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น824.10-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น662.20-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น133.95-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น86.78-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.58-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น366.94-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA